Prevalence of anemia in patients with chronic kidney disease attended at a nephrology outpatient clinic and its association with the outcome of renal replacement therapy over five years: a retrospective cohort study, Municipality of São Paulo, 2010-2018
Authors:
- Andre Kiyoshi MiyaharaAMAndre Kiyoshi Miyahara
- Pedro Henrique Moretti PepatoPPPedro Henrique Moretti Pepato
- Júlia Ferreira RochaJRJúlia Ferreira Rocha
- Alexandre Vizzuso de OliveiraAOAlexandre Vizzuso de Oliveira
- João Vitor Bozza MaiaJMJoão Vitor Bozza Maia
- Vinicius DinizVDVinicius Diniz
- Bruno Pellozo CerqueiraBCBruno Pellozo Cerqueira
- Maria Amelia Aguiar HazinMHMaria Amelia Aguiar Hazin
- Maria Eugenia Fernandes CanzianiMCMaria Eugenia Fernandes Canziani
- Miguel Angelo GoesMGMiguel Angelo Goes
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 35, 20250206
Abstract
Objective: To evaluate the prevalence of anemia in patients with chronic kidney disease and its association with the need for renal replacement therapy for five years in a specialized outpatient clinic. Methods: Retrospective cohort study that included patients admitted to a nephrology outpatient clinic between 2010 and 2018 in the municipality of São Paulo. Demographic, clinical, and laboratory data were analyzed using frequencies and absolute values. Anemia was defined as a hemoglobin concentration <13 g/dL for men and <12 g/dL for women. Clinical data and the need for renal replacement therapy over five years between patients with and without anemia at admission were compared. For statistical analyses, Pearson’s chi-square and Student’s t or Mann-Whitney U tests, Kaplan-Meier curve with log-rank test, and survival analysis using Cox regression were used. Results: The study included 534 patients, 41.8% of whom were diagnosed with anemia at admission. Hypertension (35.2%) and diabetes (27.5%) were the leading causes of chronic kidney disease. In five years, 4.1% progressed to renal replacement therapy. Anemia at admission was associated with a higher risk of the outcome (hazard ratio - HR 3.24; 95% confidence interval-95%CI 1.38; 7.61). Hemoglobin level was an independent predictor of outcome (HR 0.766; 95%CI 0.593; 0.989). Conclusion: A high prevalence of anemia in chronic kidney disease was found in patients from Primary Health Care. Hemoglobin level was an independent variable associated with the outcome.Keywords
This publication has 28 references indexed in Scilit:
- Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current PerspectivesInternational Journal of Nephrology and Renovascular Disease, 2019
- Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South AfricaInternational Journal of Nephrology and Renovascular Disease, 2019
- Association of Vitamin D and secondary hyperparathyroidism with anemia in diabetic kidney diseaseJournal of Family Medicine and Primary Care, 2018
- Metabolic Acidosis and Subclinical Metabolic Acidosis in CKDJournal of the American Society of Nephrology, 2017
- Anemia in Clinical Practice—Definition and Classification: Does Hemoglobin Change With Aging?Seminars in Hematology, 2015
- Prevalence of Anemia in Chronic Kidney Disease in the United StatesPLOS ONE, 2014
- Anemia and estimated glomerular filtration rates.2014
- Mechanisms of Anemia in CKDJournal of the American Society of Nephrology, 2012
- Pathogenesis of Renal AnemiaSeminars in Nephrology, 2006
- Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities (aric) studyJACC, 2002